208 related articles for article (PubMed ID: 1326538)
1. Characterization of the structure of a low Km, rolipram-sensitive cAMP phosphodiesterase. Mapping of the catalytic domain.
Jin SL; Swinnen JV; Conti M
J Biol Chem; 1992 Sep; 267(26):18929-39. PubMed ID: 1326538
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation.
Sette C; Conti M
J Biol Chem; 1996 Jul; 271(28):16526-34. PubMed ID: 8663227
[TBL] [Abstract][Full Text] [Related]
3. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
[TBL] [Abstract][Full Text] [Related]
4. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3).
He R; Komas N; Ekholm D; Murata T; Taira M; Hockman S; Degerman E; Manganiello VC
Cell Biochem Biophys; 1998; 29(1-2):89-111. PubMed ID: 9631240
[TBL] [Abstract][Full Text] [Related]
5. Properties and hormonal regulation of two structurally related cAMP phosphodiesterases from the rat Sertoli cell.
Swinnen JV; Tsikalas KE; Conti M
J Biol Chem; 1991 Sep; 266(27):18370-7. PubMed ID: 1655746
[TBL] [Abstract][Full Text] [Related]
6. Identification of inhibitor binding sites of the cAMP-specific phosphodiesterase 4.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Apr; 13(4):287-97. PubMed ID: 11306246
[TBL] [Abstract][Full Text] [Related]
7. Partial characterization of the active site human platelet cAMP phosphodiesterase, PDE3A, by site-directed mutagenesis.
Cheung PP; Yu L; Zhang H; Colman RW
Arch Biochem Biophys; 1998 Dec; 360(1):99-104. PubMed ID: 9826434
[TBL] [Abstract][Full Text] [Related]
8. Structure of two rat genes coding for closely related rolipram-sensitive cAMP phosphodiesterases. Multiple mRNA variants originate from alternative splicing and multiple start sites.
Monaco L; Vicini E; Conti M
J Biol Chem; 1994 Jan; 269(1):347-57. PubMed ID: 8276818
[TBL] [Abstract][Full Text] [Related]
9. The short-term activation of a rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation.
Sette C; Iona S; Conti M
J Biol Chem; 1994 Mar; 269(12):9245-52. PubMed ID: 8132662
[TBL] [Abstract][Full Text] [Related]
10. Expression and mutagenesis of the catalytic domain of cGMP-inhibited phosphodiesterase (PDE3) cloned from human platelets.
Tang KM; Jang EK; Haslam RJ
Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):217-24. PubMed ID: 9173884
[TBL] [Abstract][Full Text] [Related]
11. The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE IV) reveals a multigene family.
Obernolte R; Bhakta S; Alvarez R; Bach C; Zuppan P; Mulkins M; Jarnagin K; Shelton ER
Gene; 1993 Jul; 129(2):239-47. PubMed ID: 8392015
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast.
Torphy TJ; Stadel JM; Burman M; Cieslinski LB; McLaughlin MM; White JR; Livi GP
J Biol Chem; 1992 Jan; 267(3):1798-804. PubMed ID: 1309798
[TBL] [Abstract][Full Text] [Related]
13. Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.
Jacobitz S; McLaughlin MM; Livi GP; Burman M; Torphy TJ
Mol Pharmacol; 1996 Oct; 50(4):891-9. PubMed ID: 8863835
[TBL] [Abstract][Full Text] [Related]
14. A low-Km, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain. Cloning and expression of cDNA, biochemical characterization of recombinant protein, and tissue distribution of mRNA.
McLaughlin MM; Cieslinski LB; Burman M; Torphy TJ; Livi GP
J Biol Chem; 1993 Mar; 268(9):6470-6. PubMed ID: 8384210
[TBL] [Abstract][Full Text] [Related]
15. Purification, characterization and analysis of rolipram inhibition of a human type-IVA cyclic AMP-specific phosphodiesterase expressed in yeast.
Wilson M; Sullivan M; Brown N; Houslay MD
Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):407-15. PubMed ID: 7528009
[TBL] [Abstract][Full Text] [Related]
16. Human phosphodiesterase 4A: characterization of full-length and truncated enzymes expressed in COS cells.
Owens RJ; Catterall C; Batty D; Jappy J; Russell A; Smith B; O'Connell J; Perry MJ
Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):53-60. PubMed ID: 9337850
[TBL] [Abstract][Full Text] [Related]
17. Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B. Consequences for rolipram inhibition.
McPhee I; Yarwood SJ; Scotland G; Huston E; Beard MB; Ross AH; Houslay ES; Houslay MD
J Biol Chem; 1999 Apr; 274(17):11796-810. PubMed ID: 10206997
[TBL] [Abstract][Full Text] [Related]
18. Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram.
Shakur Y; Pryde JG; Houslay MD
Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):677-86. PubMed ID: 7686364
[TBL] [Abstract][Full Text] [Related]
19. Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase.
Livi GP; Kmetz P; McHale MM; Cieslinski LB; Sathe GM; Taylor DP; Davis RL; Torphy TJ; Balcarek JM
Mol Cell Biol; 1990 Jun; 10(6):2678-86. PubMed ID: 2160582
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae.
Michaeli T; Bloom TJ; Martins T; Loughney K; Ferguson K; Riggs M; Rodgers L; Beavo JA; Wigler M
J Biol Chem; 1993 Jun; 268(17):12925-32. PubMed ID: 8389765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
